Indaptus Therapeutics Inc is trading 7.1% down at $3.43 as the stock undergoes a period of profit-taking following a volatile two-week rally that saw shares more than double from early-June levels.
- The pullback follows a significant momentum-driven surge and a technical breakout above the 50-day moving average occurring on June 10, 2026.
- With no fresh company-specific news reported this morning, the decline is characterized as normal volatility for a high-risk micro-cap biotech following its recent sharp gains.